Join the Fentanyl group to help and get support from people like you.
Fentanyl News (Page 2)
More Than 1 in 6 U.S. Adults, Teens Have Substance Use Disorder
TUESDAY, NOV. 14, 2023 (Healthday News) – Over 1 in 6 Americans, adults and teens alike, suffered a substance use disorder in 2022, new government data released Monday shows. In the survey, alcohol ...
One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUD
WEDNESDAY, Nov. 8, 2023 – For individuals with opioid use disorder (OUD) using fentanyl, a one-day induction of extended‐release buprenorphine is a feasible treatment approach, according to a study p...
Concurrent Use of Fentanyl, Stimulants Common in Overdoses
FRIDAY, Sept. 15, 2023 – By 2021, stimulants were the most common drug class found in fentanyl-involved overdoses, according to a study published online Sept. 13 in Addiction. Joseph Friedman,...
Fatal ODs Involving Fentanyl Plus Coke, Meth Rose 50-Fold Over a Decade
THURSDAY, Sept. 14, 2023 – The "fourth wave" of the U.S. overdose crisis involves the use of illicit fentanyl mixed with stimulants such as cocaine or methamphetamine, and it’s killing people in d...
Overdose Deaths Involving Counterfeit Pills Increasing in U.S.
WEDNESDAY, Sept. 6, 2023 – There has been an increase in the percentage of drug overdose deaths with evidence of counterfeit pill use in the United States, according to a study published in the...
New Opioids Are Joining the Illicit Drug Supply, and They're More Potent Than Fentanyl
TUESDAY, Sept. 5, 2023 – In recent years, the opioid epidemic has been worsened by the advent of street fentanyl, an illicit version of a powerful prescription painkiller. But experts now warn that...
Counterfeit Pills Fuel Rising Number of Fatal Drug Overdoses
FRIDAY, Sept. 1, 2023 – A growing number of overdose deaths in the United States involve counterfeit pills, health officials reported Thursday. Overdose deaths involving counterfeit pills were twice...
Narcan Will Reach Drug Store Shelves Next Week
WEDNESDAY, Aug. 30, 2023 – Narcan (naloxone), a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week. People who want to...
FDA Medwatch Alert: Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error
April 27, 2023, Parsippany, NJ – Teva Pharmaceuticals USA, has initiated a voluntary nationwide recall of specific lots of various strengths of Fentanyl Buccal Tablets CII to the Consumer Level....
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs
November 8, 2022 -- Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...
FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs
November 8, 2022 -- Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...
FDA Medwatch Alert: Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling
April 19, 2019 – Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h...
FDA Medwatch Alert: Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
ISSUE: The FDA is aware that patients undergoing treatment or management of pain are commonly given pain medicines in the spinal fluid (intrathecal administration) that are not FDA approved for use...
FDA Medwatch Alert: Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination
ISSUE: SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. There is a potential for the products to contain microbial co...
Further information
Related condition support groups
Breakthrough Pain, Anesthesia, Chronic Pain, Pain, Sedation